Streetbeat News

Stock Prices

ALGS

Aligos Therapeutics shares are trading lower following the announcement of results from its Phase 2a HERALD study.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 7:13 pm

KO

Unusual options activity in Coca-Cola (NYSE:KO) suggests a bullish sentiment among investors, with 60% of the activity being bullish calls. This indicates potential positive movement in Coca-Cola's stock price, despite a recent 1.37% decline.

Portfolio Pulse from Benzinga Insights

September 19, 2024 | 7:05 pm

AMGN

Amgen (NASDAQ:AMGN) has seen unusual options activity, with significant investors showing a mixed sentiment. The options trades suggest a price range of $280 to $370 for Amgen, with a current trading price of $336.52. The stock is up by 1.08% and may be approaching overbought territory.

Portfolio Pulse from Benzinga Insights

September 19, 2024 | 7:05 pm

VRTX

Vertex Pharmaceuticals (NASDAQ:VRTX) has received mixed analyst ratings, with a recent increase in average price targets. Analysts have raised their price targets, reflecting a positive outlook despite the company's financial challenges, such as low net margin and ROE. Vertex's market cap is strong, and it continues to innovate in drug development.

Portfolio Pulse from Benzinga Insights

September 19, 2024 | 7:05 pm

CBUS

Cibus (NASDAQ:CBUS) has received bullish ratings from 4 analysts over the past three months, with a positive shift in average price targets. The company's financial performance shows strong revenue growth and effective debt management, despite negative net margins and returns. Analysts have adjusted their price targets, reflecting evolving market conditions.

Portfolio Pulse from Benzinga Insights

September 19, 2024 | 7:03 pm

ABT

Piper Sandler initiated coverage on Abbott Laboratories (NYSE:ABT) with an Overweight rating and a price target of $131, citing its attractive valuation and strong growth prospects in the medtech sector. Despite ongoing litigation, Abbott's diversified business model and consistent dividend payments make it a top large-cap medtech company.

Portfolio Pulse from Vandana Singh

September 19, 2024 | 7:03 pm

ARBUSD

Arbitrum (ARB) has seen a significant price increase of 11.22% in the last 24 hours, continuing its positive trend over the past week. The trading volume has surged by 115%, and the circulating supply has increased by 3.43%. The current market cap is $2.08 billion, ranking it #46.

Portfolio Pulse from Benzinga Insights

September 19, 2024 | 7:02 pm

TSLA

Tesla has filed a patent for a wireless charging system, which may be showcased at its upcoming robotaxi event on October 10. The patent could indicate new technology for Tesla's autonomous vehicles, potentially enhancing safety and efficiency. Investors are closely watching Tesla ahead of the event, which was delayed for design changes.

Portfolio Pulse from Chris Katje

September 19, 2024 | 7:00 pm

ETCUSD

Ethereum Classic (ETC) has seen a 5.87% price increase in the last 24 hours, continuing a positive trend with a 3% gain over the past week. Trading volume has surged by 84%, and the circulating supply has slightly increased. ETC's market cap is $2.82 billion, ranking it #37.

Portfolio Pulse from Benzinga Insights

September 19, 2024 | 7:00 pm